KeyBanc Capital Markets近日对Rapid Micro Biosystems Inc (NASDAQ: RPID )启动跟踪，给予"增持"评级，目标价为8.00美元。KeyBanc分析师认为，该公司创新的微生物生长直接检测系统（GDS）是生物制造质量控制领域的重大进步。

Fintel reports that on February 11, 2025, Keybanc upgraded their outlook for monday.com (NasdaqGS:MNDY) from Sector Weight to ...

Fintel reports that on February 11, 2025, Keybanc upgraded their outlook for Steel Dynamics (NasdaqGS:STLD) from Sector ...

We recently published a list of 10 Best Nasdaq Stocks Under $5 to Buy. In this article, we are going to take a look at where ...

In the first week of February, the market experienced little changes as investors analyzed earnings reports from big tech companies, a better-than-anticipated January jobs report, and updates ...

周三，TD Securities将Shopify（NYSE: ...